2020
DOI: 10.4103/1450-1147.277249
|View full text |Cite
|
Sign up to set email alerts
|

Comparison between sentinel lymph node hybrid scintigraphy and blue dye technique in breast cancer patients: An institutional experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…7,15 SPECT/CT, however, may not be advised for all breast cancer patients due to additional cost and irradiation-although it is deemed safe for pregnant surgeons and patients. 5 Nonetheless, current evidence suggests that it is indicated whenever planar imaging is difficult to interpret, equivocal, or negative. 7 Newer tracers such as indocyanine green (ICG) have also been successfully developed for SLNM.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…7,15 SPECT/CT, however, may not be advised for all breast cancer patients due to additional cost and irradiation-although it is deemed safe for pregnant surgeons and patients. 5 Nonetheless, current evidence suggests that it is indicated whenever planar imaging is difficult to interpret, equivocal, or negative. 7 Newer tracers such as indocyanine green (ICG) have also been successfully developed for SLNM.…”
Section: Discussionmentioning
confidence: 99%
“…2,3 Combining blue dye with radioisotope was found to yield a superior IR and FNR compared to using either tracer alone. 1,4,5 Although no standard methodology exists, the dual tracer technique (DTT) is considered as the gold-standard in many guidelines. Recently, single-photon emission computed-tomography/computed-tomography (SPECT/CT) was also incorporated in the preoperative SLNM workflow.…”
Section: Introductionmentioning
confidence: 99%
“…5 Regarding radioactivity, attention should be paid to the "hottest" SLN, and all nodes counted as 10% or more of the hottest node should be removed (the "10% rule"). 6 Krzhivitskii et al 7 believed that increased tracer uptake with/without LN expansion can be used as markers of tumor metastasis. Taking the histopathological results as a reference, the accuracy of mixed SPECT and CT imaging in diagnosing early stage breast cancer clinically negative LN patients with axillary LN metastasis can reach 99%.…”
Section: Isotopic Tracer Methodsmentioning
confidence: 99%
“…If the afferent lymphatic vessels cannot be identified, the first LN that appears is defined as SLN 5 . Regarding radioactivity, attention should be paid to the “hottest” SLN, and all nodes counted as 10% or more of the hottest node should be removed (the “10% rule”) 6 . Krzhivitskii et al 7 believed that increased tracer uptake with/without LN expansion can be used as markers of tumor metastasis.…”
Section: Isotopic Tracer Methodsmentioning
confidence: 99%